BioNTech SE (BNTX) EBIAT (2018 - 2025)
Historic EBIAT for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$33.6 million.
- BioNTech SE's EBIAT fell 11542.21% to -$33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$631.2 million, marking a year-over-year decrease of 2574.71%. This contributed to the annual value of -$710.9 million for FY2024, which is 17102.64% down from last year.
- Latest data reveals that BioNTech SE reported EBIAT of -$33.6 million as of Q3 2025, which was down 11542.21% from -$437.6 million recorded in Q2 2025.
- BioNTech SE's 5-year EBIAT high stood at $4.2 billion for Q1 2022, and its period low was -$869.9 million during Q2 2024.
- Its 5-year average for EBIAT is $1.1 billion, with a median of $492.7 million in 2023.
- In the last 5 years, BioNTech SE's EBIAT soared by 82798755377.65% in 2021 and then plummeted by 31957.5% in 2024.
- Over the past 5 years, BioNTech SE's EBIAT (Quarter) stood at $3.6 billion in 2021, then tumbled by 35.81% to $2.3 billion in 2022, then tumbled by 78.81% to $492.7 million in 2023, then tumbled by 43.72% to $277.3 million in 2024, then plummeted by 112.1% to -$33.6 million in 2025.
- Its EBIAT was -$33.6 million in Q3 2025, compared to -$437.6 million in Q2 2025 and -$437.4 million in Q1 2025.